•The patent infringement trial in the suit brought by Teva Pharmaceuticals against Momenta and Sandoz concerning our generic Copaxone has concluded. No decision has been issued.DOES ANYONE HAVE A OPINION ON HOW THIS WILL BE PLAYED OUT ?IS IT A BIG OVERHANG ISSUE ON PPS ?thanks
It is huge. If MNTA can sell copaxone it not only increases the bank account but it tells the world that they are not a "one-trick pony."
This is a two part game. One is the suit with TEVA. does momenta win or wait till patent expiration . The second is when or if MNTA even gets FDA approval to sell Mcopax. Lots of moving parts all of them overhang the pps.